NHI drug pricing policies to enforce unreasonably.

The government's NHI drug pricing policies seemed to be so unreasonably revised continuously that most of the domestic drug industry had to bear serious management damages.

In an excuse of the NHI price policy amelioration the MOHW stressed only on the NHI financial saving, which eventually affected substantial business troubles to all pharmaceutical companies being trapped in a deep pricing...